On July 10th, 2019, President Donald Trump announced an executive order launching the Advancing American Kidney Health (AAKH) Initiative, a three-pronged strategy aimed at improving outcomes for patients living with kidney disease by changing the way that advanced chronic kidney disease is detected, treated, and paid for in the United States.1 Not since President Richard Nixon signed into law the landmark Medicare End-Stage Renal Disease Program on July 1, 1973 has kidney disease in the United States received such attention from the federal government.